Increased risk of MAFLD and liver fibrosis in inflammatory bowel disease Independent of classic metabolic risk factors

Article

Clinical Gastroenterology and Hepatology, 2023, 21(2), 406-414

 Authorship: JUAN CARLOS RODRÍGUEZ-DUQUE, JOSÉ LUIS CALLEJA, PAULA IRUZUBIETA COZ, MARTA HERNÁNDEZ-CONDE, CORAL RIVAS-RIVAS, MARÍA ISABEL VERA, MARÍA JOSÉ GARCÍA, MARTA PASCUAL, BEATRIZ CASTRO, AGUSTIN GARCIA BLANCO, ENRIQUE GARCÍA-NIETO, SORAYA CURIEL DEL OLMO, MARIA LUISA CAGIGAL COBO, LORENA LÓPEZ-MONTEJO, TATIANA FERNÁNDEZ-LAMAS, LAURA RASINES, JOSE IGNACIO FORTEA ORMAECHEA, JOSE PEDRO VAQUE DIEZ, YZA FRÍAS, MONTSERRAT RIVERO TIRADO, MARIA TERESA ARIAS LOSTE, JAVIER CRESPO GARCIA

 2023

High accuracy of spleen stiffness measurement in diagnosing clinically significant portal hypertension in metabolic-associated fatty liver disease

Article

Liver International, 2023, 43, 1446-1457

 Authorship: AITOR ODRIOZOLA, ANGELA MARIA PUENTE SANCHEZ, ANTONIO CUADRADO LAVIN, PAULA IRUZUBIETA COZ, MARIA TERESA ARIAS LOSTE, CARLOS GODOFREDO REDONDO FIGUERO, CORAL RIVAS, EMILIO FABREGA GARCIA, JAVIER CRESPO GARCIA, JOSE IGNACIO FORTEA ORMAECHEA

 2023

Innovative therapeutic approaches in non-alcoholic fatty liver disease: when knowing your patient is key

Article

International Journal of Molecular Sciences, 2023, 24(13), 10718

 Authorship: MARTA ALONSO PEÑA, MARÍA DEL BARRIO AZACETA, ANA PELETEIRO VIGIL, CAROLINA JIMÉNEZ GONZÁLEZ, ALVARO SANTOS LASO, MARIA TERESA ARIAS LOSTE, PAULA IRUZUBIETA COZ, JAVIER CRESPO GARCIA

 2023

Faecal microbiota transplantation, paving the way to treat non-alcoholic fatty liver disease

Article

International journal of molecular sciences, 2023, 24(7), 6123

 Authorship: MARÍA DEL BARRIO, LUCÍA LAVÍN, ÁLVARO SANTOS-LASO, MARIA TERESA ARIAS LOSTE, AITOR ODRIOZOLA, JUAN CARLOS RODRIGUEZ-DUQUE, CORAL RIVAS, PAULA IRUZUBIETA, JAVIER CRESPO GARCIA

 2023

Fatty liver disease, metabolism and alcohol interplay: a comprehensive review

Article

International Journal of Molecular Sciences, 2023, 24, 7791

 Authorship: AITOR ODRIOZOLA, ALVARO SANTOS LASO, MARÍA DEL BARRIO, JOAQUÍN CABEZAS, PAULA IRUZUBIETA COZ, MARIA TERESA ARIAS LOSTE, CORAL RIVAS, JUAN CARLOS RODRÍGUEZ DUQUE, ÁNGELA ANTÓN, EMILIO FABREGA GARCIA, JAVIER CRESPO GARCIA

 2023

Evaluation of metabolic dysfunction-Associated Steatotic liver disease (MASLD) terminology in different clinical settings

Article

Journal of Hepatology, 2023

 Authorship: PAULA IRUZUBIETA COZ, ALVARO SANTOS LASO, MARIA TERESA ARIAS LOSTE, JOSÉ LUIS CALLEJA, JAVIER CRESPO GARCIA

 2023

Letter to the editor: updated guidance on NAFLD screening

Article

Hepatology, 2023, 78, E89-E90

 Authorship: MARIA TERESA ARIAS LOSTE, JAVIER CRESPO GARCIA, PAULA IRUZUBIETA COZ

 2023

Immunological and senescence biomarker profiles in patients after spontaneous clearance of hepatitis C virus: gender implications for long-term health risk

Article

Immunity & ageing : I & A, 2023, 20(1), 62

 Authorship: RUBÉN MARTÍN ESCOLANO, ERICK JOAN VIDAL ALCÁNTARA, JAVIER CRESPO GARCIA, PABLO RYAN, LUIS MIGUEL REAL, JUAN IGNACIO LAZO-ÁLVAREZ, JOAQUÍN CABEZAS GONZÁLEZ, JUAN MACÍAS, MARIA TERESA ARIAS LOSTE, GUILLERMO CUEVAS, ANA VIRSEDA BERDICES, VERÓNICA BRIZ, SALVADOR RESINO, MARÍA ÁNGELES JIMENEZ SUOSA, AMANDA FERNÁNDEZ RODRIGUEZ

 2023

No evidence of association between inherited thrombophilia and increased risk of liver fibrosis

Article

United European Gastroenterology Journal, 2023, 11, 1010-1020

 Authorship: IRANZU EZCURRA, ANGELA MARIA PUENTE SANCHEZ, ANTONIO CUADRADO LAVIN, IBAI TAMAYO, PAULA IRUZUBIETA COZ, MARIA TERESA ARIAS LOSTE, FRANCISCO JOSE GONZALEZ SANCHEZ, RAUL PELLON DABEN, SARA SANCHEZ BERNAL, JUAN CRESPO DEL POZO, MARIA MERCEDES ACEBO GARCIA, MARCOS LOPEZ HOYOS, ROCIO PEREZ IGLESIAS, AMALIA CUESTA, ÁNGELA ANTÓN, VÍCTOR ECHEVARRÍA, EMILIO FABREGA GARCIA, JAVIER CRESPO GARCIA, JOSE IGNACIO FORTEA ORMAECHEA

 2023

Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology

Article

Liver International. 2022;42:1783-1792

 Authorship: JOSÉ L. CALLEJA, JESÚS RIVERA-ESTEBAN, ROCÍO ALLER, MARTA HERNÁNDEZ-CONDE, JAVIER ABAD, JUAN M. PERICÀS, HUGO G. BENITO, MIGUEL A. SERRA, AMPARO ESCUDERO, JAVIER AMPUERO, ANA LUCENA, YOLANDA SÁNCHEZ, MARIA TERESA ARIAS LOSTE, PAULA IRUZUBIETA COZ, MANUEL ROMERO-GÓMEZ, AUGUSTÍN SALVADOR, JAVIER CRESPO GARCIA

 01/08/2022

Prevalence of antinuclear antibodies in inflammatory bowel disease and seroconversion after biological therapy

Article

Therapeutic Advances in Gastroenterology, 2022, 15, 1-13

 Authorship: MARÍA JOSÉ GARCÍA, JUAN CARLOS RODRÍGUEZ-DUQUE, MARTA PASCUAL, CORAL RIVAS, BEATRIZ CASTRO, SANDRA RASO, MARCOS LOPEZ HOYOS, MARIA TERESA ARIAS LOSTE, MONTSERRAT RIVERO

 2022

Pathophysiological mechanisms in non-alcoholic fatty liver disease: from drivers to targets

Article

Biomedicines 2022, 10(1), 46, 1-48

 Authorship: ALVARO SANTOS LASO, MARIA GUTIERREZ LARRAÑAGA, MARTA ALONSO PEÑA, JUAN MANUEL MEDINA MENDEZ, PAULA IRUZUBIETA COZ, MARIA TERESA ARIAS LOSTE, MARCOS LOPEZ HOYOS, JAVIER CRESPO GARCIA

 2022

Successful Direct Acting Antiviral Therapy in Chronic Hepatitis C Normalizes IFN and IL2 Production in T Cells Together with TLR8 Expression and Functionality in Peripheral Blood Mononuclear Cells

Article

Viruses . 2021 Apr 7;13(4):635

 Authorship: MARIA TERESA ARIAS LOSTE, JOAQUIN CABEZAS GONZALEZ, SUSANA LLERENA SANTIAGO, PAULA IRUZUBIETA COZ, DAVID SAN SEGUNDO ARRIBAS, DAVID MERINO FERNANDEZ, ANTONIO CUADRADO LAVIN, JOSE PEDRO VAQUE DIEZ, MARCOS LOPEZ HOYOS, JAVIER CRESPO GARCIA

 2021

National digestive disease specialists survey on cardiovascular risk management in non-alcoholic fatty liver disease in spanish hospitals

Article

Liver Int . 2021 Jun;41(6):1243-1253

 Authorship: PAULA IRUZUBIETA, MARIA TERESA ARIAS LOSTE, JOSE IGNACIO FORTEA ORMAECHEA, ANTONIO CUADRADO LAVIN, CORAL RIVAS-RIVAS, JUAN CARLOS RODRIGUEZ-DUQUE, MARIA DEL CARMEN GARCIA IBARBIA, JOSE LUIS HERNANDEZ HERNANDEZ, JAVIER CRESPO GARCIA

 2021

Innate and Adaptive Immunity Alterations in Metabolic Associated Fatty Liver Disease and Its Implication in COVID-19 Severity

Article

Frontiers in immunology 30 March 2021

 Authorship: PATRICIA LAMADRID PEROJO, MARTA ALONSO-PEÑA, DAVID SAN SEGUNDO ARRIBAS, MARIA TERESA ARIAS LOSTE, JAVIER CRESPO GARCIA, MARCOS LOPEZ HOYOS

 30/03/2021

Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosis

Article

Data in brief, 2029, 27, 104415

 Authorship: JAVIER VAZQUEZ BOURGON, VÍCTOR ORTIZ GARCÍA DE LA FOZ, IRENE SUAREZ PEREIRA, PAULA IRUZUBIETA, MARIA TERESA ARIAS LOSTE, MARIA ESTHER SETIEN SUERO, MARIA ROSA AYESA ARRIOLA, MARCOS GOMEZ REVUELTA, JAVIER CRESPO GARCIA, BENEDICTO CRESPO FACORRO

 01/12/2019

Cannabis consumption and non-alcoholic fatty liver disease: a three years longitudinal study in first episode non-affective psychosis patients

Article

Progress in Neuro-Psychopharmacology and Biological Psychiatry, 2019, 95, 109677

 Authorship: JAVIER VAZQUEZ BOURGON, VICTOR ORTIZ GARCIA DE LA FOZ, IRENE SUAREZ PEREIRA, PAULA IRUZUBIETA, MARIA TERESA ARIAS LOSTE, MARIA ESTHER SETIEN SUERO, MARIA ROSA AYESA ARRIOLA, MARCOS GOMEZ REVUELTA, JAVIER CRESPO GARCIA, BENEDICTO CRESPO FACORRO

 01/12/2019

Applied diagnostics in liver cancer: efficient combinations of sorafenib with targeted inhibitors blocking AKT/mTOR

Article

Oncotarget, 2018, 9(56), 30869-30882

 Authorship: SUSANA LLERENA SANTIAGO, NURIA GARCIA DIAZ, SORAYA CURIEL DEL OLMO, ANTONIO MANUEL AGRAZ DOBLAS, AGUSTIN GARCIA BLANCO, HELENA PISONERO FRAGA, MARÍA VARELA, MIGUEL SANTIBAÑEZ MARGÜELLO, CARMEN ALMARAZ, LAURA CERECEDA, NEREA MARTÍNEZ, MARIA TERESA ARIAS LOSTE, ÁNGELA PUENTE, LUIS MARTIN RAMOS, CARLOS RODRIGUEZ DE LOPE MARTIN, FEDERICO JOSE CASTILLO SUESCUN, CARMEN CAGIGAS FERNANDEZ, PABLO ISIDRO, CARLOS RODRIGUEZ DE LOPE LOPEZ, MARCOS LOPEZ HOYOS, FRANCISCO JAVIER LLORCA DIAZ, JESUS AGÜERO BALBIN, BENEDICTO CRESPO FACORRO, IGNACIO VARELA EGOCHEAGA, MIGUEL ÁNGEL PIRIS, JAVIER CRESPO GARCIA, JOSE PEDRO VAQUE DIEZ

 2018

Incidence of non-alcoholic fatty liver disease and metabolic dysfunction in first episode schizophrenia and related psychotic disorders: a 3-year prospective randomized interventional study

Article

Psychopharmacology, 2016, 233(23-24), 3947-3952

 Authorship: MARÍA JOSÉ MORLÁN COARASA, MARIA TERESA ARIAS LOSTE, VICTOR ORTIZ GARCIA DE LA FOZ, OBDULIA MARTINEZ GARCIA, CARMEN ALONSO MARTÍN, JAVIER CRESPO GARCIA, MANUEL ROMERO GÓMEZ, EMILIO FABREGA GARCIA, BENEDICTO CRESPO FACORRO

 2016

The crosstalk between hypoxia and innate immunity in the development of obesity-related nonalcoholic fatty liver disease

Article

BioMed Research International, 2015, 319745

 Authorship: MARIA TERESA ARIAS LOSTE, EMILIO FABREGA GARCIA, MARCOS LOPEZ HOYOS, JAVIER CRESPO GARCIA

 2015

Presence of anti-proteinase 3 antineutrophil cytoplasmic antibodies (anti-PR3 ANCA) as serologic markers in inflammatory bowel disease.

Article

Clinical Reviews in Allergy and Immunology, 2013, 45, 109-116

 Authorship: MARIA TERESA ARIAS LOSTE, GEOVANA BONILLA, IRENE MORALEJA, MICHAEL MAHLER, MIGUEL ANGEL MIESES, BEATRIZ CASTRO, MONTSERRAT RIVERO, JAVIER CRESPO GARCIA, MARCOS LOPEZ HOYOS

 2013

Protocolo diagnóstico de la lesión ulcerosa del recto

Article

Medicine, 2012, 11(7), 445-447

 Authorship: MARIA TERESA ARIAS LOSTE, AINHOA DÍAZ, JAVIER CRESPO GARCIA

 2012

Protocolo diagnóstico del megacolon

Article

Medicine, 2012, 11(7), 448-450

 Authorship: MARIA TERESA ARIAS LOSTE, AINHOA DÍAZ, JAVIER CRESPO GARCIA

 2012

Varón de 22 años con dolor abdominal y rectorragia

Article

Medicine, 2012, 11(7), 455.e1-455.e4

 Authorship: IRENE MORALEJA, AINHOA DÍAZ, MARIA TERESA ARIAS LOSTE, JAVIER CRESPO GARCIA

 2012

Prevalencia y caracterización de la Hipertransaminasemia Asociada al Déficit de ACOX2 (HADA) en la población de Cantabria. Proyecto ANJANA

 DEPARTAMENTO DE MEDICINA Y PSIQUIATRÍA

Head: MARTA ALONSO PEÑA

Typology: Agreements and contracts art.83, University and Competitive Chairs UC

Start year: 2022

Dianas terapéuticas y biomarcadores para la medicina de precisión en MAFLD (PreMed-MAFLD)

 DEPARTAMENTO DE MEDICINA Y PSIQUIATRÍA

Head: JAVIER CRESPO GARCIA

Typology: Competitive national public projects

Start year: 2022

Monitorización del cambio de esTIlo de Vida en pacientes con hepatopatía mEtabólica grasa (proyecto MOTIVE)

Head: LAURA HERRERO URIGÜEN

Typology: Agreements and contracts art.83, University and Competitive Chairs UC

Start year: 2021

Papel de los metabolitos derivados de la microbiota intestinal en la etiopatogenia de la enfermedad de hígado graso no alcohólico

Head: ALVARO SANTOS LASO

Typology: Agreements and contracts art.83, University and Competitive Chairs UC

Start year: 2021

NASH OR ASH, A TARGETED METAGENOMICS APPROACH

 DEPARTAMENTO DE MEDICINA Y PSIQUIATRÍA

Head: PAULA IRUZUBIETA COZ

Typology: Agreements and contracts art.83, University and Competitive Chairs UC

Start year: 2019

Esteatohepatitis no alcohólica como enfermedad inflamatoria inmunomediada. Prevalencia y caracterización. Estudio INSTInCT

 DEPARTAMENTO DE MEDICINA Y PSIQUIATRÍA

Head: JAVIER CRESPO GARCIA

Typology: Competitive national public projects

Start year: 2019

Enfermedad metabólica hepática como enfermedad inflamatoria inmunomediada. Prevalencia y caracterización.

 Authorship: JUAN CARLOS RODRÍGUEZ DUQUE

 Supervision: JAVIER CRESPO GARCIA , MARIA TERESA ARIAS LOSTE 

 Defense date: 24/11/2022